TD SYNNEX (SNX) is up 8.1% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely catalyst is a strong fiscal first-quarter earnings report with results that beat expectations, alongside forward guidance that suggested continued momentum. Investors also appeared to react positively to management commentary tying demand to AI infrastructure and cloud-related spending.
Details:
Sources:
TD SYNNEX Investor Relations, WTOP, Zacks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$SNX Insider Trading Activity
$SNX insiders have traded $SNX stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $SNX stock by insiders over the last 6 months:
- RICHARD T HUME has made 0 purchases and 29 sales selling 86,848 shares for an estimated $13,787,177.
- DENNIS POLK (Hyve Solutions Executive) has made 0 purchases and 21 sales selling 49,353 shares for an estimated $7,571,227.
- PATRICK ZAMMIT (Chief Executive Officer) sold 13,900 shares for an estimated $2,384,823
- ALIM DHANJI (Chief Human Resources Officer) has made 0 purchases and 6 sales selling 1,762 shares for an estimated $272,322.
- MIRIAM ANNE MURPHY (President, Europe) has made 0 purchases and 2 sales selling 1,673 shares for an estimated $261,810.
- MERLINE SAINTIL has made 0 purchases and 3 sales selling 671 shares for an estimated $104,457.
- REYNA THOMPSON (President, North America) sold 521 shares for an estimated $81,265
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNX Hedge Fund Activity
We have seen 266 institutional investors add shares of $SNX stock to their portfolio, and 208 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,573,337 shares (-24.3%) from their portfolio in Q4 2025, for an estimated $236,362,417
- JPMORGAN CHASE & CO removed 1,540,389 shares (-39.9%) from their portfolio in Q4 2025, for an estimated $231,412,639
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 672,585 shares (-76.8%) from their portfolio in Q4 2025, for an estimated $101,042,444
- MACQUARIE GROUP LTD removed 575,875 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $86,513,701
- ALYESKA INVESTMENT GROUP, L.P. removed 559,815 shares (-67.6%) from their portfolio in Q4 2025, for an estimated $84,101,007
- AQR CAPITAL MANAGEMENT LLC added 548,180 shares (+141.8%) to their portfolio in Q4 2025, for an estimated $82,353,081
- JANE STREET GROUP, LLC added 502,772 shares (+613.3%) to their portfolio in Q4 2025, for an estimated $75,531,437
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNX Price Targets
Multiple analysts have issued price targets for $SNX recently. We have seen 4 analysts offer price targets for $SNX in the last 6 months, with a median target of $178.0.
Here are some recent targets:
- Vincent Colicchio from Barrington Research set a target price of $182.0 on 03/27/2026
- Erik Woodring from Morgan Stanley set a target price of $174.0 on 03/20/2026
- David Vogt from UBS set a target price of $193.0 on 01/09/2026
- Tim Long from Barclays set a target price of $163.0 on 01/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.